Literature DB >> 26248837

Surgery versus SABR for resectable non-small-cell lung cancer.

Lei Zhang1, Jingru Tian2, Changli Wang3.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26248837     DOI: 10.1016/S1470-2045(15)00063-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Salvage surgery after high-dose radiotherapy.

Authors:  Annemie Van Breussegem; Jeroen M Hendriks; Patrick Lauwers; Paul E Van Schil
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

2.  Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients.

Authors:  Pamela Samson; Kathleen Keogan; Traves Crabtree; Graham Colditz; Stephen Broderick; Varun Puri; Bryan Meyers
Journal:  Lung Cancer       Date:  2016-11-09       Impact factor: 5.705

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.